ESCMID rapid guidelines on Mpox Key facts Chair(s): Pikka Jokelainen, Denmark Approval date: February 2025 Expected completion: 25.04.2026 Comment: Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline…
Get to know moreVaccination of the immunocompromised host Key facts Chair(s): Olivier Epaulard, Grenoble, France Approval date: March 2023 Expected completion: May 2025 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline…
Get to know moreClinical guidelines on antibiotic surgical prophylaxis of patients colonised by multidrug-resistant bacteria before surgery Key facts Chair(s): Elda Righi, Verona, Italy Approval date: December 2019 Expected completion: December 2024 Comment: Last status report date: February 2026 Status Report…
Get to know moreNomenclature, diagnosis and treatment of acute and chronic Q fever Key facts Chair(s): Chantal Rovers, Netherlands Approval date: February 2025 Expected completion: April 2027 Comment: Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership…
Get to know moreDosing of antimicrobials in patients with renal impairment with or without RRT Key facts Chair(s): Thomas Tängdén, Uppsala, Sweden Approval date: March 2023 Expected completion: April 2025 Comment: Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline…
Get to know moreGroup A streptococcal infections Key facts Chair(s): Katherine Gibney, Australia Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline Group…
Get to know morePneumocystis pneumonia Key facts Chair(s): Alexandre Alanio, France Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline Development Steps Status Guideline Group Membership Completed Establishing Guideline Group Processes…
Get to know moreUpdate 2014 ESCMID guidelines for the management of the infection prevention & control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients Key facts Chair(s): Evelina Tacconelli, Verona, Italy Approval date: December 2020 Expected completion: April…
Get to know moreESCMID guideline on clinician-targeted interventions to optimise treatment for common acute infections in primary care Key facts Chair(s): Oliver Van Hecke, Belgium Approval date: February 2026 Expected completion: August 2026 Last status report date: February 2026 Status Report Guideline…
Get to know moreGuidelines for management of infectious complications after chimeric antigen receptor T cell therapy and bispecific antibodies for haematological malignancies Key facts Chair(s): Maddalena Giannella, Italy Approval date: February 2026 Expected completion: August 2026 Last status report date:…
Get to know more